Dr. Sid Kerkar speaks with CGT Live about how EXUMA’s TaNK platforms aim to make CAR therapy safer and faster through novel lentivector engineering

The Vice President of Research & Development, Oncology at Exuma Biotech discussed the company’s platforms, including CAR-TaNK cells.